Amy Susan Duffield MD

PubMed

• An aggressive hematolymphoid neoplasm with homozygousloss shows response to EZH2 inhibition.
  Iman Sarami, Amy S Duffield, Suchitra Sundaram, Douglas I Lin, Christian Salib
  Haematologica. 2025-06-26
• A novel 3-way translocation involving::drives AML with eosinophilia.
  Ariel Siegel, Joseph Tripodi, Dianna Hardatt, Brianna Kelly, Sebastian El Ghaity-Beckley
  Blood Neoplasia. 2025-05-01
• Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.
  Ruiqi Zhu, Courtney M Shirley, S Haihua Chu, Li Li, Bao H Nguyen
  Leukemia. 2024-07-01

Abstracts/Posters

• DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid Leukemia
  Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine Models
  Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIM
  Amy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019